Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose

Blood Purification

Volumn 41, Issue 1-3, 2016, Pages 11-17

  Bellomo, Rinaldo ^a,b   Mårtensson, Johan ^b,c   Lo, Serigne ^d   Kaukonen, Kirsi Maija ^a   Cass, Alan ^e   Gallagher, Martin ^d  

^a MONASH UNIVERSITY   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SYDNEY   (Australia)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Catheters; Continuous renal replacement therapy; Dialysis; Femoral vein; Intensive care

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULATION; APACHE; ARTICLE; BODY WEIGHT; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS CATHETER; END STAGE RENAL DISEASE; FEMORAL VEIN; GAUGE; HUMAN; JUGULAR VEIN; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SUBCLAVIAN VEIN; UNIVARIATE ANALYSIS; VASCULAR ACCESS; VEIN CATHETERIZATION; ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; CATHETER; CATHETERIZATION; CLINICAL TRIAL; CRITICAL ILLNESS; DEVICES; FEMALE; FLUID THERAPY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CATHETERIZATION; CATHETERS; CRITICAL ILLNESS; FEMALE; FEMORAL VEIN; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS;

EID: 84945122056     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000439581     Document Type: Article

References (19)

1. Joannidis M, Oudemans-van Straaten HM: Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218.
2. Parienti JJ, Mégarbane B, Fischer MO, Lautrette A, Gazui N, Marin N, et al: Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Crit Care Med 2010; 38: 1118-1125.
3. Beitland S, Sunde K, Moen H, Os I: Variability in uremic control during continuous venovenous hemodiafiltration in trauma patients. Crit Care Res Pract 2012; 2012: 869237.
4. Fealy N, Baldwin I, Bellomo R: The effect of circuit 'down-time' on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc 2002; 4: 266-270.
5. Morgan D, Ho K, Murray C, Davies H, Louw J: A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy. Am J Kidney Dis 2012; 60: 272-279.
6. Dugué AE, Levesque SP, Fischer MO, Souweine B, Mira JP, Megarbane B, et al: Vascular access sites for acute renal replacement in intensive care units. Clin J Am Soc Nephrol 2012; 7: 70-77.
7. Kim IB, Fealy N, Baldwin I, Bellomo R: Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access. Blood Purif 2011; 31: 42-46.
8. Lameire N, Kellum JA: Contrast-induced acute kidney injury and renal support for acute kidney injury: A KDIGO summary (part 2). Crit Care 2013; 17: 205.
9. Finfer S, Cass A, Gallagher M, Lee J, Su S, Bellomo R: The RENAL (randomised evaluation of normal vs. augmented level of replacement therapy) study: statistical analysis plan. Crit Care Resusc 2009; 11: 58-66.
10. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Goldsmith D, et al: Design and challenges of the randomized evaluation of normal versus augmented level replacement therapy (RENAL) trial: high-dose versus standarddose hemofiltration in acute renal failure. Blood Purif 2008; 26: 407-416.
11. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al: Intensity of continuous renalreplacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638.
12. Hryszko T, Brzosko S, Mazerska M, Malyszko J, Mysliwiec M: Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract 2004; 96:c43-c47.
13. Liangos O, Rao M, Ruthazer R, Balakrishnan VS, Modi G, Pereira BJ, et al: Factors associated with urea reduction ratio in acute renal failure. Artif Organs 2004; 28: 1076-1081.
14. Leblanc M, Fedak S, Mokris G, Paganini EP: Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol 1996; 45: 315-319.
15. Little MA, Conlon PJ, Walshe JJ: Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique. Am J Kidney Dis 2000; 36: 1135-1139.
16. Mrozek N, Lautrette A, Timsit JF, Souweine B: How to deal with dialysis catheters in the ICU setting. Ann Intensive Care 2012; 2: 48.
17. Parienti JJ, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, et al: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA 2008; 299: 2413-2422.
18. Chua HR, Schneider AG, Sherry NL, Lotfy N, Chan MJ, Galtieri J, et al: Initial and extended use of femoral versus nonfemoral double-lumen vascular catheters and catheter-related infection during continuous renal replacement therapy. Am J Kidney Dis 2014; 64: 909-917.
19. Crosswell A, Brain MJ, Roodenburg O: Vascular access site influences circuit life in continuous renal replacement therapy. Crit Care Resusc 2014; 16: 127-130.